Panakeia

Panakeia is an AI diagnostics company developing software that predicts molecular biomarker status directly from standard H&E-stained tissue images.

Its CE-marked and UKCA-certified breast cancer product reports ER, PR, and HER2 status in minutes, reducing the need for conventional laboratory testing.

The platform extends across more than 30 cancer types for research and clinical trial applications, supporting pharma partners in biomarker validation and patient stratification.